Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

SARS-CoV-2 Vaccine Breakthrough by Omicron and Delta Variants, New York, USA

3 Sept 2022

Abstract excerpt

Recently emerged SARS-CoV-2 variants have greater potential than earlier variants to cause vaccine breakthrough infections. During emergence of the Delta and Omicron variants, a matched case-control analysis used a viral genomic sequence dataset linked with demographic and vaccination information from New York, USA, to examine associations between virus lineage and patient vaccination status, patient age, vaccine...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to SARS-CoV-2 and COVID-19 Research
Share to SARS-CoV-2 detection and testing
Share to Vaccine Coverage and Hesitancy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36048774
DOI: 10.3201/eid2810.221058

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

SARS-CoV-2 Vaccine Breakthrough by Omicron and Delta Variants, New York, USAPMID 36048774Read ↗

SARS-CoV-2 vaccine breakthrough by Omicron and Delta variants: comparative assessments with New York State genomic surveillance dataSemantic proximity Read ↗

Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variantsSemantic proximity Read ↗

Comparison of the clinical features, viral shedding and immune response in vaccine breakthrough infection by the Omicron and Delta variantsSemantic proximity Read ↗

Comparison of the Clinical Features, Viral Shedding and Immune Response in Vaccine Breakthrough Infection by the Omicron and Delta VariantsSemantic proximity Read ↗

SARS-CoV-2 Vaccine-Induced Antibodies Protect Against Omicron Breakthrough InfectionSemantic proximity Read ↗

SARS-CoV-2 Omicron Variant Infection of Individuals with High Titer Neutralizing Antibodies Post-3<sup>rd</sup> mRNA Vaccine DoseSemantic proximity Read ↗

Infectious viral load in unvaccinated and vaccinated patients infected with SARS-CoV-2 WT, Delta and OmicronSemantic proximity Read ↗

Infectious viral load in unvaccinated and vaccinated patients infected with SARS-CoV-2 WT, Delta and OmicronSemantic proximity Read ↗

Clinical and genomic signatures of SARS-CoV-2 Delta breakthrough infections in New YorkSemantic proximity Read ↗

The Efficacy for the Booster Dose of Covid-19 Vaccine between Sars-Cov-2 Omicron Variant and a Two-Year Longitudinal Antibody on Wild Type ConvalescentsSemantic proximity Read ↗

Breakthrough Infections with SARS-CoV-2 Omicron Variant Despite Booster Dose of mRNA VaccineSemantic proximity Read ↗

Clinical and genomic signatures of rising SARS-CoV-2 Delta breakthrough infections in New YorkSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.